STEPS: E-cigarettes or Medication for Smoking in Substance Use Treatment
This study, called STEPS, is looking at two ways to help people who smoke and are in substance use disorder (SUD) treatment quit smoking. You would either switch completely to e-cigarettes (nicotine vapes) for twelve weeks, or you would use FDA-approved medications (combination nicotine replacement therapy like patches and lozenges) for twelve weeks to quit smoking. Both groups will also receive weekly counseling. The main goal is to see if people can stop smoking by the end of the twelve-week treatment. To join, you need to be at least 21 years old, smoke at least 5 cigarettes daily, be in outpatient SUD treatment, and have specific breath and urine test results for tobacco use. The study is currently unclear on its recruitment status.
- Study design
- This is an interventional study planning to enroll 240 participants. It compares two different approaches to quitting smoking.
- What's involved
- Participation will last 6 months, including five in-person visits and eleven virtual assessments. You will also complete a short daily diary on your phone for the first twelve weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint measures abstinence from smoking at the end of treatment (measured at 7 days).
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
At a glance
Conditions
Where it's being run
4 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Abstinence from smoking at end of treatment7 days
7-day biologically confirmed point prevelance abstinence from cigarette smoking at Week 12 end of treatment visit